Moleculin Engages Industry Veteran Adriano Treve to Explore Accelerated Strategic Partnerships

Stock Information for Cross Timbers Royalty Trust

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Cross Timbers Royalty Trust

Moleculin to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
Moleculin Reports Second Quarter 2025 Financial Results and Highlights
Moleculin Biotech, Inc. Unveils Promising Preclinical Data of Annamycin in Liver Cancer Treatment
Moleculin Participates in the Virtual Investor "What's Your Story" Summer Spotlight On-Demand Conference
JTC Team Virtual Investor "What's Your Story" Summer Spotlight On-Demand Conference Now Live
Moleculin Expands Phase 3 MIRACLE Clinical Trial into the Country of Georgia, Enrollment Update and Future Plans
Moleculin Announces $5.9 Million Public Offering
Moleculin Participates in Virtual Investor "What This Means" Segment

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.